a developer of ovel, non-invasive, liquid biopsy diagnostics for the early detection of cancer
Industry MedicalSpecialties
A.I.dvisor tells us that OCX and FONR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OCX and FONR's prices will move in lockstep.
| Ticker / NAME | Correlation To OCX | 1D Price Change % | ||
|---|---|---|---|---|
| OCX | 100% | -0.45% | ||
| FONR - OCX | 31% Poorly correlated | -2.86% | ||
| VNRX - OCX | 28% Poorly correlated | -5.15% | ||
| ELUT - OCX | 22% Poorly correlated | +1.69% | ||
| INBS - OCX | 21% Poorly correlated | -7.07% | ||
| MLSS - OCX | 21% Poorly correlated | +0.70% | ||
More | ||||